These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 5272336
1. Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Morton DL, Eilber FR, Joseph WL, Wood WC, Trahan E, Ketcham AS. Ann Surg; 1970 Oct; 172(4):740-9. PubMed ID: 5272336 [No Abstract] [Full Text] [Related]
2. [Immunotherapeutic effect of orally administered BCG on experimental lung metastasis of subcutaneous fibrosarcoma in guinea pigs]. Fujisawa S. Nihon Hifuka Gakkai Zasshi; 1982 Oct; 92(8):871-81. PubMed ID: 6983601 [No Abstract] [Full Text] [Related]
3. Immunological aspects of neoplasia: a rational basis for immunotherapy. Ann Intern Med; 1971 Apr; 74(4):587-604. PubMed ID: 4927902 [No Abstract] [Full Text] [Related]
4. Immunotherapy of human melanomas and sarcomas. Morton DL. Natl Cancer Inst Monogr; 1972 Dec; 35():375-8. PubMed ID: 4659050 [No Abstract] [Full Text] [Related]
5. Immunological studies in murine osteosarcoma. Immunogenicity, growth kinetics, and immunotherapy. Miller CW, DeBlasi RF, Fisher SJ. J Bone Joint Surg Am; 1976 Apr; 58(3):312-7. PubMed ID: 1063129 [Abstract] [Full Text] [Related]
6. Suppression of transplanted rat sarcomata mediated by Bacillus Calmette Guéin (BCG). Moore M, Lawrence N, Witherow PJ. Eur J Cancer (1965); 1974 Oct; 10(10):673-82. PubMed ID: 4533899 [No Abstract] [Full Text] [Related]
7. Immunotherapeutic trials of murine and guinea-pig solid tumors by oral administration of BCG. Tokunaga T, Taguchi S, Chino F, Murohashi T. Jpn J Med Sci Biol; 1979 Feb; 32(1):1-18. PubMed ID: 470220 [Abstract] [Full Text] [Related]
8. [Antitumor effect of bacterial preparations. 1. Effect of BCG on tumors of guinea pigs]. Tokunaga T, Kataoka T. Nihon Saikingaku Zasshi; 1975 Jan; 30(1):214. PubMed ID: 1240246 [No Abstract] [Full Text] [Related]
9. Prospects for tumor immunotherapy in man, with emphasis on its use as an adjunct to surgery for primary operable cancer. Southam CM. J Med Liban; 1975 Jan; 28(1):43-66. PubMed ID: 1107552 [No Abstract] [Full Text] [Related]
10. Proceedings: Host immune responses in B.C.G. therapy of a rat osteosarcoma. Lawrence N, Moore M. Br J Cancer; 1974 Jan; 29(1):95. PubMed ID: 4522736 [No Abstract] [Full Text] [Related]
14. [Problems of the immunotherapy of malignant neoplasma]. Trapeznikov NN, Iavorskiĭ VV. Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178 [No Abstract] [Full Text] [Related]
15. BCG as adjuvant immunotherapy for neoplasia. Hersh EM, Gutterman JU, Mavligit GM. Annu Rev Med; 1977 May; 28():489-515. PubMed ID: 324372 [No Abstract] [Full Text] [Related]
16. Effect of Mycobacterium bovis BCG-Praha on the growth of transplanted Daels' sarcoma in guinea-pigs. Schwartz E. Neoplasma; 1973 May; 20(4):375-86. PubMed ID: 4580793 [No Abstract] [Full Text] [Related]
17. Immunotherapy of autochthomous rat methylcholanthrene-induced sarcomas with a mixture of allogeneic tumor cells and BCG-CWS. Kudo H, Suga M, Waga T, Ogasawara M, Sato T, Usubuchi I. Tohoku J Exp Med; 1980 Jan; 130(1):49-53. PubMed ID: 7368205 [Abstract] [Full Text] [Related]
18. Effect of immunotherapy on the kinetics of proliferation of a transplanted rat rhabdomyosarcoma. Gia DT, Loisillier F. Eur J Cancer (1965); 1978 Oct; 14(10):1077-88. PubMed ID: 710477 [No Abstract] [Full Text] [Related]
19. [Current status of immunotherapy of malignant tumors]. Flad HD, Betzler M, Herfarth C. Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730 [No Abstract] [Full Text] [Related]